Sarilumab，一种新的白细胞介素-6受体阻滞剂:类风湿关节炎患者的药理特性、临床疗效和安全性

{"title":"Sarilumab，一种新的白细胞介素-6受体阻滞剂:类风湿关节炎患者的药理特性、临床疗效和安全性","authors":"P. Novikov, S. Moiseev","doi":"10.32756/0869-5490-2019-4-37-42","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10353,"journal":{"name":"Clinical pharmacology and therapy","volume":"20 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Sarilumab, a new interleukin-6 receptor blocker: pharmacological properties, clinical efficacy, and safety in patients with rheumatoid arthritis\",\"authors\":\"P. Novikov, S. Moiseev\",\"doi\":\"10.32756/0869-5490-2019-4-37-42\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":10353,\"journal\":{\"name\":\"Clinical pharmacology and therapy\",\"volume\":\"20 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical pharmacology and therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.32756/0869-5490-2019-4-37-42\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical pharmacology and therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32756/0869-5490-2019-4-37-42","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}